News Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023 Continue Reading Previous Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPDNext Accenture Invests in Open Cosmos to Expand Access to Satellite Data Related Stories News Nomad Internet Launches Nomad Omni Data, Offering the World’s First Dual Network Access Through a Single Modem News Combat Holiday Stress and Protect Your Immunity with LAC This Christmas! News Veganuary for Pets News Asia’s flagship toy fair kicks off 2025 trade shows News SPRG Steps Confidently into its 30th Year of Development News Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy
